2785. Characterization of Methicillin-resistant Staphylococcus aureus Bloodstream Isolates Recovered from Patients Enrolled in a Randomized, Double-blind, Multi-center Study to Establish the Efficacy and Safety of Ceftobiprole for Treatment of Bacteremia, Including Infective Endocarditis

BACKGROUND: A Phase 3 clinical trial evaluated ceftobiprole (BPR) for the treatment of Staphylococcus aureus bacteremia (SAB), including right-sided infective endocarditis (NCT03138733). We reported molecular characteristics of methicillin-resistant S. aureus (MRSA) along with the clinical outcomes....

Descripción completa

Detalles Bibliográficos
Autores principales: Mendes, Rodrigo E, Duncan, Leonard R, Kimbrough, John H, Holland, Thomas L, Fowler, Vance G, Jones, Mark E, Engelhardt, Marc, Smart, Jennifer, Castanheira, Mariana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677102/
http://dx.doi.org/10.1093/ofid/ofad500.2396

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677102/
http://dx.doi.org/10.1093/ofid/ofad500.2396

Ejemplares similares